BRCA1 and breast carcinoma: In summary, 1,25(OH)2D may protect against breast cancer by activating its receptor and inactivating the CTSL-mediated degradation of TP53BP1 in A-type lamin-deficient cells, which display BRCA1 deficiency, including cells with lost BRCA1.